HCV Infection in the United States

Size: px
Start display at page:

Download "HCV Infection in the United States"

Transcription

1 New York State Department of Health HCV Infection in the United States ~4 million in the U.S. infected with chronic hepatitis C virus (HCV) 17,000 new infections per year 75 percent of adults with hepatitis C are baby boomers In the next 10 years, cost estimated > $80 billion 1 Deaths from HCV exceed deaths from HIV 2 New, more effective treatments 75% Undiagnosed 25% 75% of those infected with HCV are undiagnosed 1 McHutchison, J. Chronic Hepatitis C: An age wave of disease burden. Am J Manag Care Oct;11(10 Suppl):S Holmberg, Ly, Xing. The increasing burden of mortality from viral hepatitis in the United States. Ann Intern Med Jul 17;157(2):150. 1

2 OraQuick Rapid HCV Antibody Test The first and only FDAapproved rapid HCV antibody test for use with: Fingerstick whole blood Venipuncture whole blood Results in just 20 minutes Clinical performance with >98% accuracy CLIA waived OraQuick Rapid HCV Antibody Test - Intended Use Persons with signs or symptoms of hepatitis and persons at risk for hepatitis C infection Individuals 15 years of age and older Not for use with women known to be pregnant 2

3 Who to test? Had ever injected illegal drugs Were ever on chronic hemodialysis Received blood transfusions or solid organ transplants before July 1992 Received clotting factor concentrates made before 1987 Known exposure to Hepatitis C Living with HIV Has signs or symptoms of liver disease (persistent abnormal ALT) Children born to mothers who have Hepatitis C Adults born from 1945 through 1965 should receive e one-time testing for HCV without prior ascertainment of HCV risk factor status Current CDC Risk and Medical Indication-Based Guidelines, 1998 NEW CDC Expanded HCV Screening Recommendations, August 16, 2012 Benefits to Using HCV Rapid Testing at LHD STD Clinics Serve at-risk populations Already offer wide array of services, including hepatitis vaccination Can run HIV and HCV rapid tests side by side More appealing to clients Same day results Finger stick Convenient one-stop shop More appealing to staff Finger stick vs. blood draw 3

4 NYS HCV Rapid Testing Program Launched in April 2012 FREE HCV rapid test kits available to programs serving at risk individuals Program eligibility Infrastructure to support rapid testing Valid CLIA permit Polices and procedures QC Plan Blood borne pathogen policy Space/equipment Staff Training Data collection and reporting Written linkage agreement with provider Minimum can perform HCV diagnostic testing No other resources to purchase test kits HCV Rapid Test Algorithm Rapid Test Reactive Result Referral* HCV diagnostic testing * Exploring the option for on-site HCV diagnostic testing 4

5 Referrals and Referral Tracking Programs must have written linkage agreements for referrals At a minimum, provider that can perform HCV diagnostic testing (HCV RNA by PCR) Referral appointments must be tracked Release of information signed by clients On-going Requirements for Enrolled Programs Monthly Data Reporting Periodic conference calls Announced site visits Monitor compliance Provide TA Facilitate successful implementation and quality service delivery 5

6 Ordering Test Kits Ordering application on NYSDOH Health Commerce System website Must show proof of linkage agreement Kits shipped from NYSDOH Distribution Center Controls shipped from OraSure Staff Training Opportunities Web cast for program administrators Overview of the OraSure HCV rapid test and statewide screening program Integrating HIV and HCV screening Basic information about HCV transmission, epidemiology, spectrum of illness, diagnosis and treatment. Participants will learn how to deliver HIV and HCV pre and post test messages Training web site: 6

7 New Educational Materials Booklet and on-line video targeting g young people (< 30 years of age) Highlights HCV prevention messages for IDU, tattoo and body piercing To be posted on MTV Hepatitis B and C Testing Palm Cards 7

8 Technical Assistance NYSDOH HCV Rapid Testing Program Colleen Flanigan Device training, questions related to test device Tricia Stampfli Staff Training on HIV, STD and Viral Hepatitis Additional Resources NYSDOH Hepatitis Web Site titi Click on Hepatitis C Rapid Antibody Testing OraSure Technologies, Inc. Centers for Disease Control and Prevention 8

9 Contact Information Colleen Flanigan

National Hepatitis Testing Day Events and Initiatives in NYC and NYS

National Hepatitis Testing Day Events and Initiatives in NYC and NYS National Hepatitis Testing Day Events and Initiatives in NYC and NYS The Battle against Hepatitis C in A RARE 1 2 May 3 Including On-Site HCV Testing Congers, Rockland County, NY May 12, 2012, 9 am - 12

More information

Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial.

Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial. Does the Addition of HCV Testing to a Rapid HIV Testing Program Impact HIV Test Acceptance? A Randomized Controlled Trial. Yvette Calderon, MD MS 1,2, Ethan Cowan, MD MS 1,2, Rajesh Verma, MD 1, Mark Iscoe

More information

Hepatitis C Best Practice Guidelines For Local Health Departments

Hepatitis C Best Practice Guidelines For Local Health Departments Hepatitis C Best Practice Guidelines For Local Health Departments LHDs are responsible for investigating and reporting all physician reported cases of acute hepatitis C (HCV). For clients known to have

More information

Bruce A. Luxon, MD, PhD, FACG Consultant: Vertex Speakers Bureau: Merck

Bruce A. Luxon, MD, PhD, FACG Consultant: Vertex Speakers Bureau: Merck Bruce A. Luxon, MD, PhD, FACG Consultant: Vertex Speakers Bureau: Merck Bruce A. Luxon, MD, Ph.D. Anton and Margaret Fuisz Chair in Medicine Professor and Chair Department of Medicine Georgetown University

More information

OraSure Technologies. JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014

OraSure Technologies. JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014 OraSure Technologies JEFFERIES 2014 GLOBAL HEALTHCARE CONFERENCE June 4, 2014 Forward-Looking Statements These slides and the associated presentation contain certain forward-looking statements, including

More information

Targeted Outreach & Other Strategies for Increasing HCV Testing

Targeted Outreach & Other Strategies for Increasing HCV Testing Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department

More information

Hepatitis C What is it? Should I get tested?

Hepatitis C What is it? Should I get tested? Hepatitis C What is it? Should I get tested? Everything you need to know about hepatitis C Mazzoni Center Hepatitis A, B, and C are different diseases, and the viruses are spread in different ways. liver

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #400 (NQF 3059): One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Digestive & Liver Disease Wellness

Digestive & Liver Disease Wellness Digestive & Liver Disease Wellness Colorectal Cancer Screening & Prevention According to the American Cancer Society, this year 136,830 people in the U.S. According will be to diagnosed the American with

More information

Integrating Hepatitis C into Drug Treatment Settings

Integrating Hepatitis C into Drug Treatment Settings Integrating Hepatitis C into Drug Treatment Settings Substance Use Disorders Statewide Conference August 24, 2017 Pomona, CA Christine Rodriguez, MPH California Department of Public Health 1. Hepatitis

More information

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test Complexity: WAIVED for fingerstick whole blood and venipuncture whole blood. A Certificate of CLIA Waiver is required to perform the test

More information

You, Your Liver and Hepatitis C

You, Your Liver and Hepatitis C You, Your Liver and Hepatitis C Hilda Ortiz-Morales NP, PhD Montefiore Medical Center HIV-HCV Program Coordinator New York State Department of Health Anatomy Function Absorbs good nutrients Stores sugar

More information

HIV Screening & Consent for Testing

HIV Screening & Consent for Testing 1. Algorithm for HIV Screening 2. Screening & Consent for HIV Testing a. Offering testing b. Counseling on HIV Risk Factors c. Pre-test Counseling d. Post-test Counseling 1. Positive Result 2. Preliminary

More information

Epidemiology and Screening for Hepatitis C Infection

Epidemiology and Screening for Hepatitis C Infection Epidemiology and Screening for Hepatitis C Infection Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Epidemiology/Screening for Hepatitis

More information

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap

More information

HIV Prevention, Hepatitis Programming, and Drug User Health An Integrated Service Model at SFDPH. Protecting and Promoting Health and Equity

HIV Prevention, Hepatitis Programming, and Drug User Health An Integrated Service Model at SFDPH. Protecting and Promoting Health and Equity HIV Prevention, Hepatitis Programming, and Drug User Health An Integrated Service Model at SFDPH Protecting and Promoting Health and Equity CHE&P 3/12/15 Presented by: Katie Burk, MPH 1 San Francisco Department

More information

Hepatitis C and Innovative Public Health Practice

Hepatitis C and Innovative Public Health Practice Hepatitis C and Innovative Public Health Practice Ann Thomas MD, MPH Ann Shindo, PhD, MSW, MPH, MS Oregon Public Health Division Prevalence of anti-hcv Prevalence of Anti-HCV* (US,1999 2002 NHANES**) Overall

More information

BioTherapeutics. Diagnostic and Pharmaceutical News for You and Your Medical Practice

BioTherapeutics. Diagnostic and Pharmaceutical News for You and Your Medical Practice BQ Diagnostic and Pharmaceutical News for You and Your Medical Practice BioTherapeutics Q u a r t e r l y Volume 13/Fall 2013 13MS8876 Image: Influenza Virus 2 3 4 Q u a r t e r l y Volume 13/Fall 2013

More information

The Alphabet Soup of Viral Hepatitis Testing

The Alphabet Soup of Viral Hepatitis Testing The Alphabet Soup of Viral Hepatitis Testing August 18, 2011 Patricia Slev, PhD, DABCC Medical Director, Serologic Hepatitis and Retrovirus Laboratory, ARUP Laboratories Assistant Professor of Pathology,

More information

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [60Day-12-12MW]

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [60Day-12-12MW] Billing Code: 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-12-12MW] Proposed Data Collections Submitted for Public Comment and Recommendations In

More information

8. Quality Assurance Guidelines (Includes Appendices A-G)

8. Quality Assurance Guidelines (Includes Appendices A-G) 8. Quality Assurance Guidelines (Includes Appendices A-G) Quality Assurance Guidelines for Testing Using the OraQuick HCV Rapid Antibody Test This document has been modified by OraSure Technologies from

More information

Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD

Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD Prevent Hepatocellular Carcinoma through Screening, Vaccination, and Treatment of Viral Hepatitis Milena Gould Suarez, MD Hello, my name is Milena Gould Suarez, and today I will present "Prevent Hepatocellular

More information

Hepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, :00 pm 1:00 pm

Hepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, :00 pm 1:00 pm Hepatitis C Virus (HCV) & Infectious Disease 101 for Hubs & Spokes April 24, 2018 12:00 pm 1:00 pm Presenters: Thomas E. Freese, PhD, Larissa Mooney, MD, & Rachel McLean, MPH, Chief, Office of Viral Hepatitis

More information

NIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at:

NIH Consensus Conference Statement. Management of Hepatitis C. March 24-26, NIH Web site. Available at: ABC s of Hepatitis C Treatment Today Elizabeth N. Britton, MSN, FNP-BC Hepatology Services Louisiana State University Health Sciences Center ebritt@lsuhsc.edu ANAC CONFERENCE -TUCSON NOV 2012 Hepatitis

More information

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences

Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious Disease & Laboratory Sciences Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Michael Gaucher and Shauna Onofrey MA Department of Public Health Bureau of Infectious

More information

Geo-epidemiology of Hepatitis C in Northeast Indiana

Geo-epidemiology of Hepatitis C in Northeast Indiana Geo-epidemiology of Hepatitis C in Northeast Indiana Shori Gerardot, Ashley Cross, Atit Patel, Kassidy Beck MS, Scott M. Stienecker MD, and Teresa A. Beam PhD Hepatitis C (HCV) ~180 million worldwide ~2.7-3.9

More information

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38

HEPATITIS C, ACUTE CRUDE DATA. Number of Cases 5 Annual Incidence a LA County 0.05 California b 0.10 United States b 0.68 Age at Diagnosis Mean 38 2016 Annual Morbidity Report HEPATITIS C, ACUTE a Rates calculated based on less than 19 cases or events are considered unreliable b Calculated from: CDC. Notice to Readers: Final 2016 Reports of Nationally

More information

@PremierHA #AdvisorLive. Download today s slides at

@PremierHA #AdvisorLive. Download today s slides at @PremierHA #AdvisorLive Download today s slides at www.premierinc.com/events Logistics Audio Use your computer speakers or dial in with the number on your screen Notes Download today s slides from the

More information

Viral Hepatitis Surveillance in Tennessee

Viral Hepatitis Surveillance in Tennessee Viral Hepatitis Surveillance in Tennessee NASTAD Viral Hepatitis TA Meeting November 29, 2017 Lindsey Sizemore, Viral Hepatitis Program Director Turning of The Tides HIV Risk Vulnerability Assessment Webinar

More information

Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E.

Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E. What is Hepatitis? Hepatitis is an epidemic disease that can be caused by different viruses including hepatitis viruses A, B, C, D or E. Hepatitis A and E are not chronic and are mostly present in areas

More information

HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis

HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis HCV in the Latino Community -Epidemiology, Natural History, Risk Factors, Screening and Diagnosis Wari Allison MD, PhD Assistant Professor/Research Dept. of Medicine/Infectious Disease Medical Director

More information

HepCure : An innovative web-based toolkit to support the treatment of hepatitis C at community health centers in New York State

HepCure : An innovative web-based toolkit to support the treatment of hepatitis C at community health centers in New York State HepCure : An innovative web-based toolkit to support the treatment of hepatitis C at community health centers in New York State CHCANYS 15: Statewide Conference & Clinical Forum October 19, 2015 Jeffrey

More information

Hepatitis C. Core slides

Hepatitis C. Core slides Hepatitis C Core slides This material was prepared by the Viral Hepatitis Prevention Board The slides (or subsets) can be reproduced for educational use only, with reference to the original source and

More information

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014

Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014 Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations Emily McCloskey USCA October 3, 2014 About NASTAD NASTAD is an international non-profit association of U.S. state

More information

Perinatal Hepatitis b Prevention

Perinatal Hepatitis b Prevention Perinatal Hepatitis b Prevention Purpose 2 The primary goal of the Perinatal Hepatitis b Prevention Program (PHBPP) is to identify all pregnant women who are infected with hepatitis b and prevent perinatal

More information

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges

26/09/2014. Types of Viral Hepatitis. Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Rate per, Types of Viral Hepatitis A E B D C Prevention of Viral Hepatitis as a Health Disparity for American Indians: Successes and Challenges Source of virus Feces Feces Blood/bloodderived body fluids

More information

Available In person Courses

Available In person Courses Course Catalogue for HIV Education and Training NY www.hivtrainingny.org The NYSDOH AIDS Institute s HIV, STI and Viral Hepatitis Training Programs offer trainings on HIV/AIDS, sexually transmitted infection

More information

DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland

DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General 18-1001, Hepatitis C Prevention and Control within Maryland Submitted by: Maryland Department of Health and Mental Hygiene

More information

Hepatitis C Screening For Baby Boomers in Primary Care. Nicole Mesick DO, RD NHAFP Conference May 18 th, 2018

Hepatitis C Screening For Baby Boomers in Primary Care. Nicole Mesick DO, RD NHAFP Conference May 18 th, 2018 Hepatitis C Screening For Baby Boomers in Primary Care Nicole Mesick DO, RD NHAFP Conference May 18 th, 2018 Disclosures No disclosures Objectives Recognize the importance of diagnosing Hepatitis C (HCV)

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.

More information

Hepatitis Case Investigation

Hepatitis Case Investigation * indicates required fields Does patient also have: Hepatitis Case Investigation West Virginia Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology

More information

WHAT IS HEPATITIS C? 2 DOES HEPATITIS C AFFECT PREGNANCY? HOW DO I GET TREATED FOR HEPATITIS C?

WHAT IS HEPATITIS C? 2 DOES HEPATITIS C AFFECT PREGNANCY? HOW DO I GET TREATED FOR HEPATITIS C? 1 TABLE OF CONTENTS WHAT IS HEPATITIS C? 2 HOW DO PEOPLE GET INFECTED WITH HEPATITIS C? 4 HOW DOES HEPATITIS C AFFECT MY BODY? 6 DOES HEPATITIS C AFFECT PREGNANCY? 8 HOW DO I GET TESTED FOR HEPATITIS C?

More information

Hepatitis C in Massachusetts Epidemiology and Public Health Response

Hepatitis C in Massachusetts Epidemiology and Public Health Response Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Epidemiology and Public Health Response Shauna Onofrey, MPH, Viral Hepatitis

More information

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003

Hepatitis STARS Program. Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Hepatitis 2003 STARS Program Geri Brown, M.D. Associate Professor Department of Internal Medicine October 4, 2003 Outline n Hepatitis A Epidemiology and screening Transmission n Hepatitis B Epidemiology

More information

Get Hip to Hep: Partnerships for Prevention

Get Hip to Hep: Partnerships for Prevention Get Hip to Hep: Partnerships for Prevention California Immunization Coalition Summit, Sacramento, May 3, 2010 Overview 1. Introduce the California Adult Viral Hepatitis Prevention Strategic Plan 2. Highlight

More information

HEPATITIS C TREATMENT UPDATE

HEPATITIS C TREATMENT UPDATE HEPATITIS C TREATMENT UPDATE Hepatitis C: Burden of Disease in USA HCV is generally asymptomatic until advanced liver disease 4.1 million persons ever infected; 3.2 million chronic infections Up to 75%

More information

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond

SFDPH Responds to Hepatitis C: Strategic Directions for and Beyond SFDPH Responds to Hepatitis C: Strategic Directions for 2015-2016 and Beyond Presented by: Kelly Eagen, MD Physician Specialist Tom Waddell Urban Health San Francisco Health Network Katie Burk, MPH Viral

More information

Florida House of Representatives HB A-02

Florida House of Representatives HB A-02 By Representatives Brutus, Wilson, Rubio, Smith, Meadows, Prieguez, Arza, Garcia, Diaz-Balart and Betancourt 1 A bill to be entitled 2 An act relating to human immunodeficiency 3 virus; amending s. 381.0046,

More information

Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians

Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians Shana Geary, MPH, CPH United States Conference on AIDS September 7,

More information

Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.

Note: Staff who work in case management programs should attend the AIDS Institute training, Addressing Prevention in HIV Case Management. Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting

More information

Introduction and Background

Introduction and Background Table of Contents Preface and Acknowledgements... i Introduction and Background... 1 Testing Session... 10 Antibody Negative/Nonreactive Test Results... 18 Antibody Positive/Reactive Test Result... 25

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result

More information

who use drugs in order to assist them in reducing harm while in the cycle of addiction

who use drugs in order to assist them in reducing harm while in the cycle of addiction August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who

More information

HEPATITIS C VIRUS: NEW DIAGNOSTIC TOOLS By (hepatitis)

HEPATITIS C VIRUS: NEW DIAGNOSTIC TOOLS By (hepatitis) HEPATITIS C VIRUS: NEW DIAGNOSTIC TOOLS By (hepatitis) If looking for the book by (hepatitis) HEPATITIS C VIRUS: NEW DIAGNOSTIC TOOLS in pdf form, then you've come to the right website. We present full

More information

Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings

Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings Opportunities For Hepatitis C Modalities in Substance Use Treatment Settings KATIE BURK, MPH VIRAL HEPATITIS COORDINATOR SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH 1 Webinar Outline 1. HCV Overview 2. SFDPH

More information

CHAPTER 2 NETWORK PROVIDER/SERVICE DELIVERY REQUIREMENTS

CHAPTER 2 NETWORK PROVIDER/SERVICE DELIVERY REQUIREMENTS CHAPTER 2 NETWORK PROVIDER/SERVICE DELIVERY REQUIREMENTS 2.9 SPECIAL POPULATIONS ADHS/DBHS receives Federal grants and State appropriations to deliver behavioral health services to special populations

More information

Hepatitis C. No disclosures. 1. The USPSTF recommends Hepatitis C screening in which patient populations?

Hepatitis C. No disclosures. 1. The USPSTF recommends Hepatitis C screening in which patient populations? Hepatitis C Jennifer Acosta PA-C No disclosures 1. The USPSTF recommends Hepatitis C screening in which patient populations? a. All adults at least once b. Immigrants to the US and those over age 65 c.

More information

Agenda. Hepatitis C: Evaluation & Treatment. Background. Natural History of Hepatitis C. Epidemiology 9/23/2014

Agenda. Hepatitis C: Evaluation & Treatment. Background. Natural History of Hepatitis C. Epidemiology 9/23/2014 Hepatitis C: Evaluation & Treatment Amanda DeVoss, MMS, PA-C WAPA Conference Fall 2014 adevoss@wisc.edu Background Epidemiology Transmission Screening Agenda Diagnosis Evaluation Treatment Background Natural

More information

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Viral Hepatitis Burden and Policy Directions in the European Region of WHO Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all

More information

Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD

Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD Hepatitis B Epidemiology and Prevention in the Elimination Era John W. Ward, MD Director, Program for Viral Hepatitis Elimination, Task Force for Global Health Senior Scientist, National Center for HIV/AIDS,

More information

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA

US Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA US Proposal to Transform Response to Hepatitis B and C Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA US Proposal to Transform Response to Hepatitis B and C Burden of disease Deficiencies

More information

HCV Testing Challenges & Systems-based Solutions

HCV Testing Challenges & Systems-based Solutions HCV Testing Challenges & Systems-based Solutions Webcast 2.3 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department Communicable Disease Control Program Manager Webcast Overview 1

More information

Hepatitis Trivia Game

Hepatitis Trivia Game Hepatitis Trivia Game Materials: 30 cards with a multiple-choice, fill-in-the-blank, or true/false question written on them. Facilitator s answer sheet Description Trivia Game gives participants the opportunity

More information

Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings MAMTA K. JAIN, MD, MPH 2/14/18

Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings MAMTA K. JAIN, MD, MPH 2/14/18 Hepatitis C Infection: Updated Information for Front Line Workers in Primary Care Settings MAMTA K. JAIN, MD, MPH 2/14/18 Overview Hepatitis C Virus Prevalence Effects of Hepatitis C Prevention Diagnosis

More information

INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT

INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT INTEGRATED HCV SCREENING AND TESTING IN SUBSTANCE ABUSE TREATMENT HEPATITIS Hepatitis is the name for a family of viral infections that affect the liver. The most common types are Hepatitis A, B, and C.

More information

HIV SELF-TESTING AFRICA

HIV SELF-TESTING AFRICA UNITAID PSI HIV SELF-TESTING AFRICA Zambart: Interim Results of Clinical Performance Study Alwyn Mwinga Overview of Presentation Study Objectives Clinical Performance study Visual stability study Progress

More information

Hepatitis Update. Tom Bendle Hepatitis Program Manager STD & Viral Hepatitis Section Bureau of Communicable Diseases

Hepatitis Update. Tom Bendle Hepatitis Program Manager STD & Viral Hepatitis Section Bureau of Communicable Diseases Hepatitis Update Tom Bendle Hepatitis Program Manager STD & Viral Hepatitis Section Bureau of Communicable Diseases Division of Disease Control and Health Protection To protect, promote and improve the

More information

REPORTED PAST/PRESENT HEPATITIS C CASES IN ALLEGHENY COUNTY, PENSYLVANIA, FROM : A DESCRIPTIVE ANALYSIS. Alison Feathers

REPORTED PAST/PRESENT HEPATITIS C CASES IN ALLEGHENY COUNTY, PENSYLVANIA, FROM : A DESCRIPTIVE ANALYSIS. Alison Feathers REPORTED PAST/PRESENT HEPATITIS C CASES IN ALLEGHENY COUNTY, PENSYLVANIA, FROM 2007-2016: A DESCRIPTIVE ANALYSIS by Alison Feathers BS Biology, West Virginia University, 2014 Submitted to the Graduate

More information

Commonly Asked Questions About Chronic Hepatitis C

Commonly Asked Questions About Chronic Hepatitis C Commonly Asked Questions About Chronic Hepatitis C From the American College of Gastroenterology 1. How common is the hepatitis C virus? The hepatitis C virus is the most common cause of chronic viral

More information

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016

NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016 NYS PrEP Programming March 21, 2016 Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016 March 21, 2016 2 New York State Priorities

More information

Hepatitis C: Let s Talk About It. Causes of Hepatitis

Hepatitis C: Let s Talk About It. Causes of Hepatitis Hepatitis C: Let s Talk About It Susan Thompson, RN, MPH Technical Assistance and Training Program NC Communicable Disease Branch July 2012 Causes of Hepatitis any swelling, inflammation, or irritation

More information

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period

Definition: Active injection drug users - Those who have injected any drug(s) within the 12 month reporting period Quality ID #387 (NQF 3060): Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL

More information

Welcome to Your Reading Assignment

Welcome to Your Reading Assignment Welcome to Your Reading Assignment This workbook contains four reading assignments. It is filled with easy-to-read articles you can use to help keep yourself and those you care about safe. After each reading

More information

HIV Testing Technology and the Latest Algorithm

HIV Testing Technology and the Latest Algorithm HIV Testing Technology and the Latest Algorithm David Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene HIV Testing has changed over time Patients with

More information

Rapid testing algorithm performance in a low prevalence environment: NJ

Rapid testing algorithm performance in a low prevalence environment: NJ Rapid testing algorithm performance in a low prevalence environment: NJ 2015-8 Alere Determine HIV-1/2 Ag/Ab Combo Trinity Biotech Uni-Gold HIV1/2 Recombigen Eugene G. Martin, PhD HIV Diagnostics Conference

More information

Hepatitis C Virus (HCV)

Hepatitis C Virus (HCV) Clinical Practice Guidelines Hepatitis C Virus (HCV) OBJECTIVE The purpose is to guide the appropriate diagnosis and management of Hepatitis C Virus (HCV). GUIDELINE These are only guidelines, and are

More information

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS Unigold Recombigen HIV 1/2 Training for HIV Testing Sites Updated: February 2018 Cicely Richard Office of HIV/AIDS Updated: February 2018 Cicely Richard Office of HIV/AIDS UNIGOLD RECOMBIGEN HIV 1/2 TRAINING

More information

Greater Glasgow and Clyde. Blood Borne Viruses: Some important basic facts

Greater Glasgow and Clyde. Blood Borne Viruses: Some important basic facts Greater Glasgow and Clyde Blood Borne Viruses: Some important basic facts Greater Glasgow and Clyde Blood Borne Viruses: Some important basic facts A programme developed by Greater Glasgow and Clyde Health

More information

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital

Viral Hepatitis. Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis Dr Melissa Haines Gastroenterologist Waikato Hospital Viral Hepatitis HAV HBV HCV HDV HEV Other viral: CMV, EBV, HSV Unknown Hepatitis A Hepatitis A Transmitted via the faecal-oral route

More information

Hepatitis C: Surveillance, Case Definition, and Investigation

Hepatitis C: Surveillance, Case Definition, and Investigation Hepatitis C: Surveillance, Case Definition, and Investigation Tuesday, November 14, 2017 10am 11:30am NJ Department of Health Communicable Disease Service Welcome to the Webinar Today s webinar is being

More information

Viral Hepatitis. WHO Regional Office for Europe July 2013

Viral Hepatitis. WHO Regional Office for Europe July 2013 Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,

More information

Implementation of testing (and other interventions along the Continuum of Care)

Implementation of testing (and other interventions along the Continuum of Care) Implementation of testing (and other interventions along the Continuum of Care) Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control

More information

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States

More information

HIV Testing. Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center

HIV Testing. Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center HIV Testing Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center The Number of Persons in the US Living with HIV Continues to Increase Over 1 Million people are estimated

More information

GLOBAL AIDS MONITORING REPORT

GLOBAL AIDS MONITORING REPORT KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017

More information

PS : Comprehensive HIV Prevention Programs for Health Departments

PS : Comprehensive HIV Prevention Programs for Health Departments PS12-1201: Comprehensive HIV Prevention Programs for Health Departments Program Overview Erica K. Dunbar, MPH Program Leader, Health Department Initiatives National Center for HIV/AIDS, Viral Hepatitis,

More information

The Case of Houston Health Department Perinatal Hepatitis B Prevention Program

The Case of Houston Health Department Perinatal Hepatitis B Prevention Program The Case of Houston Health Department Perinatal Hepatitis B Prevention Program Essi M. Havor, MSN, RN, APHN-BC Chief Nurse Immunization Program 2018 TX PHBPP SUMMIT Upon completion of this presentation,

More information

THE BIRTH-COHORT EVALUATION TO ADVANCE SCREENING

THE BIRTH-COHORT EVALUATION TO ADVANCE SCREENING THE BIRTH-COHORT EVALUATION TO ADVANCE SCREENING AND TESTING FOR HEPATITIS C (BEST-C) Prepared April 21, 2010 CDC CONTACT Bryce D. Smith, Ph.D. Research Health Scientist Prevention Research and Evaluation

More information

Hepatitis C Virus Infection Among Young Drug Users What Can Viral Hepatitis Coordinators and Health Departments Do?

Hepatitis C Virus Infection Among Young Drug Users What Can Viral Hepatitis Coordinators and Health Departments Do? Hepatitis C Virus Infection Among Young Drug Users What Can Viral Hepatitis Coordinators and Health Departments Do? Dan Church Massachusetts Department of Public Health Bureau of Infectious Disease 1 Goals

More information

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER Objective Epidemiology Screening criteria Appropriate work up Treatment Guidelines

More information

NationalHepatitisCPrevention Strategy

NationalHepatitisCPrevention Strategy NationalHepatitisCPrevention Strategy 2001 National Hepatitis C Prevention Strategy A Comprehensive Strategy for the Prevention and Control of Hepatitis C Virus Infection and its Consequences Division

More information

Planning for Action at the Local Level

Planning for Action at the Local Level Planning for Action at the Local Level Webcast 2.1 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department Communicable Disease Control Program Manager Webcast Overview 1 Developments

More information

Hepatitis C January 26, 2018

Hepatitis C January 26, 2018 Hepatitis C January 26, 2018 Case Investigation Guidelines Contents A. Purpose...2 B. Case Definitions...2 a. Acute Hepatitis C (2016...2 b. Chronic Hepatitis C (2016)...3 c. Perinatal Hepatitis C (2017

More information

Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006

Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006 DOI 10.1007/s10995-015-1853-4 Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006 L. Ghazaryan 1 L. Smith 2 M. Parker 3 C. Flanigan 4 W. Pulver 2 T. Sullivan 5 A.

More information

Hepatitis C : Screening and Prevention Strategies

Hepatitis C : Screening and Prevention Strategies Hepatitis C : Screening and Prevention Strategies JAMEELA J. YUSUFF, MD MPH FACP MEDICAL DIRECTOR STAR HEALTH CENTER AT SUNY DOWNSTATE MEDICAL CENTER JANUARY 24, 2018 Overview Review of Screening Guidelines

More information

SUBJECT: Hepatitis C Virus (HCV) Counseling/Education, Testing, Referral, and Partner Notification

SUBJECT: Hepatitis C Virus (HCV) Counseling/Education, Testing, Referral, and Partner Notification SUBJECT: Hepatitis C Virus (HCV) Counseling/Education, Testing, Referral, and Partner Notification Hepatitis C virus (HCV) infection is the most common chronic bloodborne infection in the United States.

More information

ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES

ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES ADDRESSING VIRAL HEPATITIS IN PEOPLE WITH SUBSTANCE USE DISORDERS: A THREE (3) PART SERIES David Njabulo Whiters, PhD, MSW, NCAC II Consultant, Great Lakes Addiction Technology Transfer Center Setting

More information

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary

Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is

More information

WORKING TOWARD A HEP FREE NYC HEPATITIS A, B AND C IN NEW YORK CITY: 2017 ANNUAL REPORT NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE

WORKING TOWARD A HEP FREE NYC HEPATITIS A, B AND C IN NEW YORK CITY: 2017 ANNUAL REPORT NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE WORKING TOWARD A HEP FREE NYC HEPATITIS A, B AND C IN NEW YORK CITY: 2017 ANNUAL REPORT NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE TABLE OF CONTENTS 1. SUMMARY... 4 2. SURVEILLANCE Hepatitis

More information